Later on, the same group reported that common variants in BARD1 gene were associated with high-risk neuroblastoma [13], and polymorphisms within DUSP12, DDX4, IL31RA, and HSD17B12 were associated with low-risk neuroblastoma [14]. This evidence concerns the gene IL31RA and neuroblastoma.